Cargando…

Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review

BACKGROUND: Cardiac amyloidosis (CA) is primarily a restrictive cardiomyopathy in which the impairment of diastolic function is dominant. Despite this, the left ventricular ejection fraction (LVEF) may be depressed in the late stage of the disease, but it poorly predicts prognosis in the earlier pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matteo, Serenelli, Anna, Cantone, Federico, Sanguettoli, Daniele, Maio, Gioele, Fabbri, Beatrice, Dal Passo, Rita, Pavasini, Elisabetta, Tonet, Giulia, Passarini, Claudio, Rapezzi, Gianluca, Campo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911429/ https://www.ncbi.nlm.nih.gov/pubmed/36776259 http://dx.doi.org/10.3389/fcvm.2023.1085824

Ejemplares similares

Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications
por: Fabbri, Gioele, et al.
Publicado: (2021)

Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta‐analysis
por: Cantone, Anna, et al.
Publicado: (2023)

The treatment of amyloidosis is being refined
por: Cantone, Anna, et al.
Publicado: (2022)

The role of stress echocardiography in transcatheter aortic valve implantation and transcatheter edge-to-edge repair era: A systematic review
por: Pavasini, Rita, et al.
Publicado: (2022)

The left atrium in cardiac amyloidosis: a valuable but still underused observation window on the overall disease process
por: Rapezzi, Claudio, et al.
Publicado: (2021)

Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome
por: Pavasini, Rita, et al.
Publicado: (2022)

The Use of Multimodality Imaging for the Diagnosis of Myocardial Outpouchings and Invaginations: A Systematic Review
por: Pavasini, Rita, et al.
Publicado: (2023)

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)

Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index
por: Tolomeo, Paolo, et al.
Publicado: (2022)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

Coronary Microvascular Dysfunction: PET, CMR and CT Assessment
por: Tonet, Elisabetta, et al.
Publicado: (2021)

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
por: Brito, Dulce, et al.
Publicado: (2023)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease
por: Pavasini, Rita, et al.
Publicado: (2021)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

Standard ECG in Brugada Syndrome as a Marker of Prognosis: From Risk Stratification to Pathophysiological Insights
por: Vitali, Francesco, et al.
Publicado: (2021)

Diagnosis and treatment of transthyretin‐related amyloidosis cardiomyopathy
por: Teng, Catherine, et al.
Publicado: (2020)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Frailty in patients admitted to hospital for acute coronary syndrome: when, how and why?
por: Tonet, Elisabetta, et al.
Publicado: (2019)

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Campbell, Courtney M., et al.
Publicado: (2022)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies
por: Pavasini, Rita, et al.
Publicado: (2021)

A new therapy for transthyretin amyloidosis, no longer an orphan condition
por: Quarta, Candida Cristina, et al.
Publicado: (2020)

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?
por: Rapezzi, Claudio, et al.
Publicado: (2021)

Guideline of transthyretin-related hereditary amyloidosis for clinicians
por: Ando, Yukio, et al.
Publicado: (2013)

Mitra-clip in Transthyretin Amyloidosis Cardiomyopathy A Case Series
por: Cuddy, Sarah, et al.
Publicado: (2020)

Healthcare resource use associated with the diagnosis of transthyretin amyloidosis cardiomyopathy
por: Asher, Clint, et al.
Publicado: (2022)

Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery
por: Porcari, Aldostefano, et al.
Publicado: (2020)

Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2022)

Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology
por: Skrahina, Volha, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Systemic embolism in amyloid transthyretin cardiomyopathy
por: Vilches, Silvia, et al.
Publicado: (2022)

Risk stratification in transthyretin-related cardiac amyloidosis
por: Scirpa, Riccardo, et al.
Publicado: (2023)

Pulmonary Valve Stenosis: From Diagnosis to Current Management Techniques and Future Prospects
por: Marchini, Federico, et al.
Publicado: (2023)

Hereditary transthyretine amyloidosis in Slovenia
por: Zidar, Janez
Publicado: (2015)

Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis
por: Salvalaggio, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kan5ucb8pvqc9goobrnu3h1iib